• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用遗传编码的非天然氨基酸合成双特异性抗体。

Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

机构信息

Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

出版信息

J Am Chem Soc. 2012 Jun 20;134(24):9918-21. doi: 10.1021/ja303904e. Epub 2012 Jun 6.

DOI:10.1021/ja303904e
PMID:22642368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4299457/
Abstract

Bispecific antibodies were constructed using genetically encoded unnatural amino acids with orthogonal chemical reactivity. A two-step process afforded homogeneous products in excellent yield. Using this approach, we synthesized an anti-HER2/anti-CD3 bispecific antibody, which efficiently cross-linked HER2+ cells and CD3+ cells. In vitro effector-cell mediated cytotoxicity was observed at picomolar concentrations.

摘要

双特异性抗体是使用具有正交化学反应性的遗传编码非天然氨基酸构建的。两步法以优异的收率得到均相产物。使用这种方法,我们合成了一种抗 HER2/抗 CD3 双特异性抗体,它能有效地交联 HER2+细胞和 CD3+细胞。在皮摩尔浓度下观察到体外效应细胞介导的细胞毒性。

相似文献

1
Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.使用遗传编码的非天然氨基酸合成双特异性抗体。
J Am Chem Soc. 2012 Jun 20;134(24):9918-21. doi: 10.1021/ja303904e. Epub 2012 Jun 6.
2
Bispecific HER2 x CD3 antibodies enhance T-cell cytotoxicity in vitro and localize to HER2-overexpressing xenografts in nude mice.双特异性HER2 x CD3抗体在体外增强T细胞细胞毒性,并在裸鼠体内定位于HER2过表达的异种移植瘤。
Clin Immunol Immunopathol. 1995 Feb;74(2):185-92. doi: 10.1006/clin.1995.1027.
3
Engineering Bifunctional Antibodies with Constant Region Fusion Architectures.工程化具有恒定区融合结构的双功能抗体。
J Am Chem Soc. 2017 Dec 27;139(51):18607-18615. doi: 10.1021/jacs.7b09641. Epub 2017 Dec 14.
4
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.基于亲和力的 HER2 结合导致抗 HER2/CD3 选择性杀伤过表达 HER2 的细胞。
Sci Transl Med. 2018 Oct 17;10(463). doi: 10.1126/scitranslmed.aat5775.
5
Anti-HER-2 anti-CD3 bi-specific antibodies inhibit growth of HCT-116 colorectal carcinoma cells in vitro and in vivo.抗HER-2抗CD3双特异性抗体在体外和体内均可抑制HCT-116结肠癌细胞的生长。
Asian Pac J Cancer Prev. 2012;13(6):2795-8. doi: 10.7314/apjcp.2012.13.6.2795.
6
A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells.一种新型不对称抗 HER2/CD3 双特异性抗体对 HER2 阳性肿瘤细胞表现出强大的细胞毒性。
J Exp Clin Cancer Res. 2019 Aug 14;38(1):355. doi: 10.1186/s13046-019-1354-1.
7
Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab')2 for efficient lysis of p185HER2 overexpressing tumor cells.工程化高亲和力人源化抗p185HER2/抗CD3双特异性F(ab')2以有效裂解p185HER2过表达的肿瘤细胞。
Int J Cancer. 1995 Jul 28;62(3):319-24. doi: 10.1002/ijc.2910620315.
8
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.靶向臂亲和力决定抗 HER2/CD3 双特异性抗体的临床前疗效和安全性。
JCI Insight. 2020 Apr 9;5(7):133757. doi: 10.1172/jci.insight.133757.
9
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers.可切换的 CAR-T 细胞在针对乳腺癌的传统抗体导向治疗中表现更佳。
ACS Synth Biol. 2021 May 21;10(5):1176-1183. doi: 10.1021/acssynbio.1c00007. Epub 2021 Apr 15.
10
Multiformat T-cell-engaging bispecific antibodies targeting human breast cancers.靶向人类乳腺癌的多格式T细胞衔接双特异性抗体。
Angew Chem Int Ed Engl. 2015 Jun 8;54(24):7022-7. doi: 10.1002/anie.201500799. Epub 2015 Apr 27.

引用本文的文献

1
Cracking the Code: Reprogramming the Genetic Script in Prokaryotes and Eukaryotes to Harness the Power of Noncanonical Amino Acids.破解密码:在原核生物和真核生物中重新编程遗传密码以利用非规范氨基酸的力量。
Chem Rev. 2024 Sep 25;124(18):10281-10362. doi: 10.1021/acs.chemrev.3c00878. Epub 2024 Aug 9.
2
Macrophage-engaging peptidic bispecific antibodies (pBsAbs) for immunotherapy a facile bioconjugation strategy.用于免疫治疗的巨噬细胞结合肽双特异性抗体(pBsAbs):一种简便的生物共轭策略。
Chem Sci. 2024 Apr 30;15(29):11272-11278. doi: 10.1039/d4sc00851k. eCollection 2024 Jul 24.
3
Promotion and Detection of Cell-Cell Interactions through a Bioorthogonal Approach.通过生物正交方法促进和检测细胞-细胞相互作用。
J Am Chem Soc. 2024 Jun 26;146(25):17334-17347. doi: 10.1021/jacs.4c04317. Epub 2024 May 20.
4
Introduction of Carbonyl Groups into Antibodies.引入羰基基团到抗体中。
Molecules. 2023 Dec 1;28(23):7890. doi: 10.3390/molecules28237890.
5
Applications of genetic code expansion technology in eukaryotes.遗传密码扩展技术在真核生物中的应用。
Protein Cell. 2024 May 7;15(5):331-363. doi: 10.1093/procel/pwad051.
6
Site-specific protein conjugates incorporating Para-Azido-L-Phenylalanine for cellular and in vivo imaging.用于细胞和体内成像的结合了对叠氮基-L-苯丙氨酸的位点特异性蛋白质缀合物。
Methods. 2023 Nov;219:95-101. doi: 10.1016/j.ymeth.2023.10.001. Epub 2023 Oct 5.
7
Selective and Site-Specific Incorporation of Nonstandard Amino Acids Within Proteins for Therapeutic Applications.用于治疗应用的蛋白质中非常规氨基酸的选择性和特异性整合。
Methods Mol Biol. 2024;2720:35-53. doi: 10.1007/978-1-0716-3469-1_3.
8
Applications of synthetic biology in medical and pharmaceutical fields.合成生物学在医学和制药领域的应用。
Signal Transduct Target Ther. 2023 May 11;8(1):199. doi: 10.1038/s41392-023-01440-5.
9
The renaissance of chemically generated bispecific antibodies.化学合成双特异性抗体的复兴。
Nat Rev Chem. 2021 Feb;5(2):78-92. doi: 10.1038/s41570-020-00241-6. Epub 2021 Jan 19.
10
Aminooxy Click Modification of a Periodate-Oxidized Immunoglobulin G: A General Approach to Antibody-Drug Conjugates with Dye-Mediated Expeditious Stoichiometry Control.高碘酸钠氧化免疫球蛋白 G 的氨氧基点击修饰:一种通过染料介导的快速化学计量控制制备抗体药物偶联物的通用方法。
Int J Mol Sci. 2023 Mar 7;24(6):5134. doi: 10.3390/ijms24065134.

本文引用的文献

1
Synthesis of heterobifunctional protein fusions using copper-free click chemistry and the aldehyde tag.使用无铜点击化学和醛标签合成异双功能蛋白融合体。
Angew Chem Int Ed Engl. 2012 Apr 23;51(17):4161-5. doi: 10.1002/anie.201108130. Epub 2012 Mar 12.
2
Buy buy bispecific antibodies.买买双特异性抗体。
Nat Rev Drug Discov. 2011 Oct 31;10(11):798-800. doi: 10.1038/nrd3581.
3
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.一种针对 HER3 和 EGFR 的双特异性抗体与单特异性抗体相比具有更高的抑制活性。
Cancer Cell. 2011 Oct 18;20(4):472-86. doi: 10.1016/j.ccr.2011.09.003.
4
Selective formation of covalent protein heterodimers with an unnatural amino acid.利用非天然氨基酸选择性形成共价蛋白质异二聚体。
Chem Biol. 2011 Mar 25;18(3):299-303. doi: 10.1016/j.chembiol.2011.01.006.
5
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma.双亲和重定向分子的应用实现了对 B 细胞淋巴瘤的最优重定向 T 细胞杀伤。
Blood. 2011 Apr 28;117(17):4542-51. doi: 10.1182/blood-2010-09-306449. Epub 2011 Feb 7.
6
Site-specific coupling and sterically controlled formation of multimeric antibody fab fragments with unnatural amino acids.利用非天然氨基酸实现抗体 Fab 片段的位点特异性偶联和空间位阻控制的多聚体形成。
J Mol Biol. 2011 Mar 4;406(4):595-603. doi: 10.1016/j.jmb.2011.01.011. Epub 2011 Jan 13.
7
Chemical generation of bispecific antibodies.化学法制备双特异性抗体。
Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22611-6. doi: 10.1073/pnas.1016478108. Epub 2010 Dec 13.
8
Readily accessible bicyclononynes for bioorthogonal labeling and three-dimensional imaging of living cells.易于获取的用于生物正交标记和活细胞三维成像的双环壬炔。
Angew Chem Int Ed Engl. 2010 Dec 3;49(49):9422-5. doi: 10.1002/anie.201003761.
9
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.三功能抗体 catumaxomab 治疗上皮癌恶性腹水:前瞻性随机 2/3 期试验结果。
Int J Cancer. 2010 Nov 1;127(9):2209-21. doi: 10.1002/ijc.25423.
10
Therapeutic antibodies for autoimmunity and inflammation.自身免疫和炎症的治疗性抗体。
Nat Rev Immunol. 2010 May;10(5):301-16. doi: 10.1038/nri2761.